LSD for Obsessive-Compulsive Disorder (OCD)
1 paper and 0 clinical trials exploring lsd as a treatment for obsessive-compulsive disorder (ocd).
LSD
LSD is a classic psychedelic ergoline with high potency at microgram doses and an 8-12 hour duration of action, mediated primarily via 5-HT2A receptor agonism. Modern Phase IIb data in generalised anxiety disorder and FDA Breakthrough Therapy Designation for MM-120 have reignited clinical development.
Full LSD profileObsessive-Compulsive Disorder (OCD)
Recent research indicates that psychedelics, particularly psilocybin, are emerging as potential therapeutic agents in the treatment of Obsessive-Compulsive Disorder (OCD). Early clinical trials demonstrate promising results regarding their efficacy and safety, paving the way for future studies in this field.
Full Obsessive-Compulsive Disorder (OCD) profileAcademic Research
1 paperClinical Trials
0 trialsNo clinical trials have been tagged with both LSD and Obsessive-Compulsive Disorder (OCD) yet.
Trials are continuously being added as new studies are registered.